2-chloroacrylic acid, 98% +(stabilized with 0.3-0.5% BHT), 1g

4-amino-6-(4-methylphenyl)pyridazin-3(2{H})-one, 95.0%, 250mg

3,5-Dibromo-1-isopropyl-1H-1,2,4-triazole, 97%, 1g

3-(4-Fluorophenyl)pyrrolidine, 95.0%, 500mg

4-Methyl-1-naphthaldehyde, 100g

5-(Hydroxymethyl)pyrimidine, 95.0%, 5g

(S)-Methyl 2-amino-2-cyclohexylacetate hydrochloride, 95.0%, 10g

2,4,6-Collidine, 99.00%, 500g

trans-4'-(p-tolyl)-[1,1'-Bi(cyclohexan)]-4-one, 97%, 25g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

2-(4-Methoxyphenylcarbonothioylthio)ethanoic acid, 98%, 1g

2-{[1-(3-fluorophenyl)-1h-imidazol-2-yl]sulfanyl}acetic acid, 95+%, 100mg

tert-Butyl ((5-bromo-7-chlorobenzofuran-2-yl)methyl)carbamate, 97%, 100mg